Novartis

USA Today Profiles CEO Who 'Stands Up to Protestors'

Dan Vasella of Novartis Pharmaceuticals shares tips on confronting the opposition.

NY Times Slants Patent Protection Story Against Novartis

Reporter depicts court struggle as one pitting company against 'patients rights groups' instead of liberal activists.
Syndicate content